The scores of clinical symptoms and function after treatment and in follow-up in the saturated moxa dosage group were increased much more apparently than those in the regular moxa dosage group ( after treatment : 22.32 + / - 4.64 vs 17.43 + / - 3.21 ; in follow-up : 23.01 + / - 4.76 vs 18.32 + / - 2.13 , both P < 0.01 ) .